Viewing Study NCT05179733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-04-24 @ 10:48 AM
Study NCT ID: NCT05179733
Status: RECRUITING
Last Update Posted: 2023-05-23
First Post: 2021-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
Sponsor: Ruijin Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NHL-014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None FED View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View